Hydroxychloroquine blood levels predicts flare in childhood-onset lupus nephritis

1. Thakral, A, Klein-Gitelman, MS. An update on treatment and management of pediatric systemic lupus erythematosus. Rheumatol Ther 2016; 3: 209–219.
Google Scholar | Crossref | Medline2. Ferreira, JCOA, Trindade, VC, Espada, G, et al. Epidemiology and management practices for childhood-onset systemic lupus erythematosus patients: a survey in Latin America. Clin Rheumatol 2018; 37: 3299–3307.
Google Scholar | Crossref | Medline3. Abdulaziz, N, Shah, AR, McCune, WJ. Hydroxychloroquine: balancing the need to maintain therapeutic levels with ocular safety: an update. Curr Opin Rheumatol 2018; 30: 249–255.
Google Scholar | Crossref | Medline4. Costedoat-Chalumeau, N, Dunogué, B, Morel, N, et al. Hydroxychloroquine: a multifaceted treatment in lupus. Presse Medicale 2014; 43: e167–80.
Google Scholar | Crossref | Medline5. Rodriguez-Smith, J, Brunner, HI. Update on the treatment and outcome of systemic lupus erythematous in children. Curr Opin Rheumatol 2019; 31: 464–470.
Google Scholar | Crossref | Medline6. Koneru, S, Kocharla, L, Higgins, GC, et al. Adherence to medications in systemic lupus erythematosus. JCR: J Clin Rheumatol 2008; 14: 195–201.
Google Scholar | Crossref | Medline | ISI7. Ting, TV, Kudalkar, D, Nelson, S, et al. Usefulness of cellular text messaging for improving adherence among adolescents and young adults with systemic lupus erythematosus. J Rheumatol 2012; 39: 174–179.
Google Scholar | Crossref | Medline | ISI8. Costedoat-Chalumeau, N, Amoura, Z, Hulot, JS, et al. Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus. Arthritis Rheum 2006; 54: 3284–3290.
Google Scholar | Crossref | Medline9. Cunha, C, Alexander, S, Ashby, D, et al. Hydroxycloroquine blood concentration in lupus nephritis: a determinant of disease outcome?. Nephrol Dial Transplant 2018; 33: 1604–1610.
Google Scholar | Medline10. Marmor, MF, Kellner, U, Lai, TYY, et al. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology 2016; 123: 1386–1394.
Google Scholar | Crossref | Medline | ISI11. Pedrosa, TN, Pasoto, SG, Aikawa, NE, et al. Understanding the dynamics of hydroxychloroquine blood levels in lupus nephritis. Lupus 2020; 29: 560–568.
Google Scholar | SAGE Journals | ISI12. Matalová, P, Urbánek, K, Anzenbacher, P. Specific features of pharmacokinetics in children. Drug Metab Rev 2016; 48(1): 70–79.
Google Scholar | Crossref | Medline13. Zahr, N, Urien, S, Funck-Brentano, C, et al. Evaluation of hydroxychloroquine blood concentrations and effects in childhood-onset systemic lupus erythematosus. Pharmaceuticals 2021; 14: 273.
Google Scholar | Crossref | Medline14. Hochberg, MC . Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
Google Scholar | Crossref | Medline15. Gladman, DD, Ibañez, D, Urowitz, MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29: 288–291.
Google Scholar | Medline | ISI16. National Kidney Foundation . K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(suppl 1): S1–S266.
Google Scholar | Medline17. Schwartz, GJ, Muñoz, A, Schneider, MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20: 629–637.
Google Scholar | Crossref | Medline | ISI18. Kamakura, W, Mazzon, JA. Brazilian Criteria 2015 and social class distribution update for 2016. In: Estratificação Socioeconômica e Consumo no Brasil. 2016, 1–6.
Google Scholar19. Flegal, KM, Tabak, CJ, Ogden, CL. Overweight in children: definitions and interpretation. Health Educ Res 2006; 21: 755–760.
Google Scholar | Crossref | Medline | ISI20. Costedoat-Chalumeau, N, Galicier, L, Aumaître, O, et al. Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study). Ann Rheum Dis 2013; 72: 1786–1792.
Google Scholar | Crossref | Medline | ISI21. Malattia, C, Martini, A. Paediatric-onset systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2013; 27: 351–362.
Google Scholar | Crossref | Medline | ISI22. Rapoff, MA . Management of adherence and chronic rheumatic disease in children and adolescents. Best Pract Res Clin Rheumatology 2006; 20: 301–314.
Google Scholar | Crossref | Medline | ISI23. Pedrosa, T, Kupa, LDVK, Pasoto, SG, et al. The influence of obesity on hydroxychloroquine blood levels in lupus nephritis patients. Lupus 2021; 30: 554–559.
Google Scholar | SAGE Journals | ISI24. Jallouli, M, Galicier, L, Zahr, N, et al. Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus. Arthritis Rheumatol 2015; 67: 2176–2184.
Google Scholar | Crossref | Medline25. Raghoebar, M, Peeters, PA, van den Berg, WB, et al. Mechanisms of cell association of chloroquine to leucocytes. J Pharmacology Experimental Therapeutics 1986; 238: 302–306.
Google Scholar | Medline26. Smith, EMD, Eleuteri, A, Goilav, B, et al. A Markov Multi-State model of lupus nephritis urine biomarker panel dynamics in children: predicting changes in disease activity. Clin Immunol 2019; 198: 71–78.
Google Scholar | Crossref | Medline27. Aggarwal, A, Phatak, S, Srivastava, P, et al. Outcomes in juvenile onset lupus: single center cohort from a developing country. Lupus 2018; 27: 1867–1875.
Google Scholar | SAGE Journals | ISI

留言 (0)

沒有登入
gif